Pathophysiology Nodes

6
6 shared nodes are defined in this module.

Cell Types

1
melanopsin-expressing intrinsically photosensitive retinal ganglion cell CL:0020014 Cell Ontology (CL) Relation: this mechanism module involves this cell type This mechanism module involves melanopsin-expressing intrinsically photosensitive retinal ganglion cell (CL:0020014). CL:0020014 is a cell type from the Cell Ontology.

Biological Processes

6
circadian regulation of gene expression GO:0032922 Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves abnormal circadian regulation of gene expression (GO:0032922). GO:0032922 is a biological process from the Gene Ontology. ABNORMAL entrainment of the circadian clock by photoperiod GO:0043153 Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves decreased entrainment of the circadian clock by photoperiod (GO:0043153). GO:0043153 is a biological process from the Gene Ontology. DECREASED circadian rhythm GO:0007623 Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves abnormal circadian rhythm (GO:0007623). GO:0007623 is a biological process from the Gene Ontology. ABNORMAL entrainment of circadian clock GO:0009649 Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves decreased entrainment of circadian clock (GO:0009649). GO:0009649 is a biological process from the Gene Ontology. DECREASED regulation of the circadian sleep/wake cycle GO:0042749 Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves abnormal regulation of the circadian sleep/wake cycle (GO:0042749). GO:0042749 is a biological process from the Gene Ontology. ABNORMAL circadian sleep/wake cycle, sleep GO:0050802 Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves abnormal circadian sleep/wake cycle, sleep (GO:0050802). GO:0050802 is a biological process from the Gene Ontology. ABNORMAL
i

Notes

This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g. "circadian_phase_misalignment#Misalignment Between Endogenous Circadian Phase and the Imposed Sleep-Wake Schedule", the key conformance target and rate-limiting step). ARM SELECTION IS THE CURATOR'S FIRST DECISION, and the two arms are not interchangeable. Enter at #Intrinsic Core Clock Period or Phase Lesion only when the endogenous oscillator itself is altered - familial advanced sleep phase syndrome (PER2 S662G, CSNK1D T44A), familial delayed sleep phase disorder (CRY1 gain-of-function). Enter at #Loss or Mistiming of Photic Entrainment Input when the oscillator is normal and the light signal that should reset it is absent or arriving at the wrong time - non-24-hour sleep-wake rhythm disorder in total blindness, jet lag disorder, shift work disorder. A disorder may legitimately carry both (evening light exposure reinforcing an already-delayed phase in delayed sleep phase syndrome), but the arms should be curated as separate nodes, not merged. WHAT DOES NOT CONFORM. Misalignment is a claim about the relationship between an internal phase and an external schedule; a sleep complaint alone does not establish it. Chronic insomnia disorder, where hyperarousal prevents sleep at any phase, does not conform, and the discriminator is diagnostic rather than theoretical: in a circadian disorder, sleep is normal in structure and duration when the person is allowed to sleep at their own phase. Shortened or fragmented sleep with a normal, entrained phase belongs elsewhere. Advanced or delayed sleep timing that is a preference rather than a disorder is likewise out of scope - the module models the pathological case in which the phase cannot be moved to meet the schedule. DRUG-TARGET PATTERN. Melatonin receptor agonists (tasimelteon, melatonin) ACTIVATE #Shifted or Free-Running Endogenous Circadian Phase, supplying at a fixed clock time the phase-setting signal that light normally provides. The cleanest demonstration is in totally blind patients with non-24-hour sleep-wake rhythm disorder, where the photic route is absent altogether and a timed melatonin-receptor signal entrains the pacemaker on its own - and where withdrawal of the drug loses entrainment again, which is the evidence that the agonist substitutes for the missing input rather than curing the lesion. Appropriately timed bright light acts on the same node through the intact photic route, and is the corresponding non-pharmacological intervention. SCOPE BOUNDARIES. Distinct from orexin_arousal_instability (state instability at any time of day, with a normal clock) and from sleep_disordered_breathing_intermittent_hypoxia (sleep is correctly timed but destroyed by respiratory events). It is also distinct from glymphatic_dysfunction, which is gated by sleep state rather than by circadian phase and models a clearance consequence rather than a timing lesion. Not an Xogenesis module - a timing relationship fails, nothing pathological is formed.
?

Discussions and Knowledge Gaps

1
Is a single dim-light melatonin onset an adequate measurement of the misalignment this module makes rate-limiting?
KNOWLEDGE GAP gap_phase_marker_vs_schedule_measurement
Attached to: Misalignment Between Endogenous Circadian Phase and the Imposed Sleep-Wake Schedule
The central node is a relation between an internal phase and an imposed schedule, but in practice almost all clinical and research characterisation measures only the internal half, usually as a single dim-light melatonin onset. That leaves the relation inferred rather than measured, and it makes two clinically different situations - a pacemaker that cannot be shifted, and one that could be shifted but is being held in place by the patient's own light exposure and schedule - indistinguishable on the standard workup. It matters therapeutically, because only the second is expected to respond to behavioural light and schedule management.
Proposed experiments: Paired circadian phase and imposed-schedule assessment

Used By Disorder Entries

4

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence-backed metadata.
Pathograph: causal mechanism network for Circadian Phase Misalignment Module Interactive directed graph showing how this shared module's pathophysiology nodes connect.

Pathophysiology

6
Intrinsic Core Clock Period or Phase Lesion
trigger
First of two entry arms. The circadian pacemaker is a cell-autonomous transcription-translation negative feedback loop: CLOCK-BMAL1 drives expression of PER and CRY, whose protein products feed back to inhibit their own activators, with the loop's period set largely by the rate at which PER is phosphorylated and degraded. A variant that changes either the phosphorylation substrate (PER2 S662G, which is hypophosphorylated by casein kinase I), the kinase (CSNK1D T44A), or the repressor's affinity for its activators (a gain-of-function CRY1 variant) alters the endogenous period and therefore the phase at which the oscillator stabilises under a 24-hour light-dark cycle. A shortened period advances phase; a lengthened period delays it. Conforming disorder nodes substitute the disorder-specific clock gene and the direction of the period change.
circadian regulation of gene expression GO:0032922 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal circadian regulation of gene expression (GO:0032922). GO:0032922 is a biological process from the Gene Ontology. ABNORMAL
Loss or Mistiming of Photic Entrainment Input
trigger
Second, mechanistically distinct entry arm, in which the oscillator is intact but the signal that should set it is absent or arriving at the wrong phase. Photoentrainment does not use the image-forming visual pathway: melanopsin-expressing intrinsically photosensitive retinal ganglion cells project directly to the suprachiasmatic nucleus, and rods and cones are not required. This anatomy explains a clinically important dissociation - a person with no conscious light perception but a surviving ipRGC pathway can still entrain, while total loss of the eyes or of the retinohypothalamic projection removes entrainment entirely and the pacemaker free-runs at its own period. Conforming disorder nodes substitute the disorder-specific input lesion: absent light input (total blindness), abruptly shifted input (transmeridian travel), or chronically inverted input (night shift work).
melanopsin-expressing intrinsically photosensitive retinal ganglion cell CL:0020014 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves melanopsin-expressing intrinsically photosensitive retinal ganglion cell, annotated with intrinsically photosensitive retinal ganglion cell (CL:0020014). CL:0020014 is a cell type from the Cell Ontology.
entrainment of the circadian clock by photoperiod GO:0043153 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased entrainment of the circadian clock by photoperiod, annotated with entrainment of circadian clock by photoperiod (GO:0043153). GO:0043153 is a biological process from the Gene Ontology. DECREASED
Shifted or Free-Running Endogenous Circadian Phase
amplifier
Both arms converge here. The suprachiasmatic pacemaker holds a phase - as read out by the dim-light melatonin onset, the core body temperature minimum, and the timing of the endogenous sleep propensity window - that is abnormally advanced, abnormally delayed, or not stably locked to 24 hours at all. The distinction between a shifted and a free-running phase matters for prognosis and for treatment timing: a shifted phase is stable and can be treated at a fixed clock hour, whereas a free-running phase drifts through all clock times and produces cyclically recurring symptoms.
circadian rhythm GO:0007623 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal circadian rhythm (GO:0007623). GO:0007623 is a biological process from the Gene Ontology. ABNORMAL
Misalignment Between Endogenous Circadian Phase and the Imposed Sleep-Wake Schedule
central effector
The rate-limiting, disorder-agnostic node and the key conformance target. Misalignment is a relation, not a state of the clock alone: it requires both an endogenous phase and an externally imposed schedule that disagree. This is what makes the circadian disorders unusual - the same pacemaker phase is pathological or benign depending only on what the person is required to do, which is why an extreme evening chronotype with a permissive schedule is not a patient and the same physiology with a 07:00 start is. A conforming disorder node should name both halves of the relation.
entrainment of circadian clock GO:0009649 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased entrainment of circadian clock (GO:0009649). GO:0009649 is a biological process from the Gene Ontology. DECREASED regulation of the circadian sleep/wake cycle GO:0042749 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal regulation of the circadian sleep/wake cycle, annotated with regulation of circadian sleep/wake cycle (GO:0042749). GO:0042749 is a biological process from the Gene Ontology. ABNORMAL
Sleep Attempted at an Adverse Circadian Phase
effector
The physiological expression of misalignment. Sleep initiated during the circadian wake-maintenance zone is delayed in onset and shortened; wake required near the core body temperature minimum is accompanied by maximal sleepiness and impaired performance. The resulting sleep is curtailed rather than structurally abnormal, which is the diagnostic hallmark distinguishing this module from primary insomnia: released from the schedule, the same person sleeps normally at their own phase.
circadian sleep/wake cycle, sleep GO:0050802 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal circadian sleep/wake cycle, sleep (GO:0050802). GO:0050802 is a biological process from the Gene Ontology. ABNORMAL
Circadian Sleep-Wake Disorder Syndrome
consequence
The clinical endpoint: insomnia at the scheduled bed time, excessive sleepiness at the scheduled wake time, and impaired daytime function, with the specific complaint determined by the direction of the misalignment. Advanced phase presents as early-morning awakening and evening sleepiness; delayed phase as sleep-onset insomnia and severe morning sleep inertia; a free-running phase as symptoms that cycle in and out over weeks as the endogenous phase drifts through the imposed schedule. Conforming entries should preserve that the pattern of symptoms, not their severity, identifies the underlying misalignment.